Obagi Medical Products Inc., (NASDAQ:OMPI) trading at $19.69 gained $4.30 or 27.94% on a ... sending both shares up in the stock market this morning. Obagi is best known for Nu-Derm, a topical prescription treatment for wrinkles and …
James O’Connor, director at Pharma Glass, said it had previously been difficult to readily source from stock Ompi products in the UK and Ireland. “Pharma Glass Vials and Closures is now building up inventory to meet customer …
Another chapter has been written on the nearly year-long effort by Voce Capital management to get Obagi Medical Products (OMPI) sold. On Monday ... own due diligence before buying and selling any stock, and/or consult with a …
OMPI) ("Obagi") for a price of $24 per share in cash, without interest (less any applicable withholding taxes). The Offer …
NEW YORK (MarketWatch) — Shares of the following companies were making notable moves in the U.S. stock market Friday ... Obagi Medical Products Inc.’s OMPI shares tumbled 25% after the maker of skin creams late Thursday …
Valeant said it would buy Obagi Medical Products Inc OMPI.O for about $344 million to boost its dermatology business. Valeant shares closed at C$75.21 and played the biggest role of any single stock in leading the market higher. As a …
It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with …
MONTREAL, March 20, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX ... will …
OMPI), a dermatology products maker, for about $344 million. Montreal-based Valeant will pay $19.75 per share in cash for Obagi's stock, a 28 percent premium over the Long Beach, California-based company's closing price on Tuesday, …